Drug Shortage Report for MYLAN-BECLO AQ
Report ID | 96537 |
Drug Identification Number | 02172712 |
Brand name | MYLAN-BECLO AQ |
Common or Proper name | MYLAN-BECLO AQ |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | BECLOMETHASONE DIPROPIONATE |
Strength(s) | 50MCG |
Dosage form(s) | METERED-DOSE AEROSOL SUSPENSION |
Route of administration | NASAL |
Packaging size | 22s |
ATC code | R01AD |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2019-10-15 |
Estimated end date | Unknown |
Actual end date | 2020-03-25 |
Shortage status | Resolved |
Updated date | 2020-03-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2020-03-26 | English | Compare |
v9 | 2020-03-25 | French | Compare |
v8 | 2020-03-25 | English | Compare |
v7 | 2020-01-13 | French | Compare |
v6 | 2020-01-13 | English | Compare |
v5 | 2019-11-12 | French | Compare |
v4 | 2019-11-12 | English | Compare |
v3 | 2019-10-16 | English | Compare |
v2 | 2019-10-15 | French | Compare |
v1 | 2019-10-15 | English | Compare |
Showing 1 to 10 of 10